Illumina is trading at $188.77 (-4.79%) after no clear company-specific catalyst emerged in August 6, 2026 coverage.

  • The latest confirmed company event was July 30 Q2 results, which beat estimates and raised 2026 guidance, so it does not clearly explain today’s decline.
  • Broader technology and semiconductor weakness may be adding pressure, but Illumina is underperforming the major indices.